Advertisement
U.S. markets close in 1 hour 15 minutes

Abbott Laboratories (ABT)

NYSE - Nasdaq Real Time Price. Currency in USD
113.75+0.27 (+0.24%)
As of 02:45PM EDT. Market open.
  • Dividend

    ABT announced a cash dividend of 0.55 with an ex-date of Apr. 12, 2024

Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
40,109,000
40,109,000
43,653,000
43,075,000
34,608,000
Cost of Revenue
17,975,000
17,975,000
19,142,000
18,537,000
15,003,000
Gross Profit
22,134,000
22,134,000
24,511,000
24,538,000
19,605,000
Operating Expense
15,656,000
15,656,000
16,149,000
16,113,000
14,248,000
Operating Income
6,478,000
6,478,000
8,362,000
8,425,000
5,357,000
Net Non Operating Interest Income Expense
-252,000
-252,000
-375,000
-490,000
-500,000
Other Income Expense
438,000
438,000
319,000
276,000
111,000
Pretax Income
6,664,000
6,664,000
8,306,000
8,211,000
4,968,000
Tax Provision
941,000
941,000
1,373,000
1,140,000
497,000
Net Income Common Stockholders
5,723,000
5,723,000
6,933,000
7,071,000
4,495,000
Diluted NI Available to Com Stockholders
5,723,000
5,723,000
6,933,000
7,071,000
4,495,000
Basic EPS
2.95
3.30
3.94
3.97
2.54
Diluted EPS
2.94
3.26
3.91
3.94
2.50
Basic Average Shares
1,741,035
1,734,076
1,753,000
1,775,000
1,771,230
Diluted Average Shares
1,750,670
1,749,000
1,764,000
1,789,000
1,786,000
Total Operating Income as Reported
6,478,000
6,478,000
8,362,000
8,425,000
5,357,000
Total Expenses
33,631,000
33,631,000
35,291,000
34,650,000
29,251,000
Net Income from Continuing & Discontinued Operation
5,723,000
5,723,000
6,933,000
7,071,000
4,495,000
Normalized Income
5,758,219
5,758,219
6,934,670
7,071,861
4,463,800
Interest Income
385,000
385,000
183,000
43,000
46,000
Interest Expense
637,000
637,000
558,000
533,000
546,000
Net Interest Income
-252,000
-252,000
-375,000
-490,000
-500,000
EBIT
7,301,000
7,301,000
8,864,000
8,744,000
5,514,000
EBITDA
10,544,000
10,544,000
12,131,000
12,282,000
8,841,000
Reconciled Cost of Revenue
16,698,000
16,698,000
17,888,000
17,046,000
13,808,000
Reconciled Depreciation
3,243,000
3,243,000
3,267,000
3,538,000
3,327,000
Net Income from Continuing Operation Net Minority Interest
5,723,000
5,723,000
6,933,000
7,071,000
4,471,000
Total Unusual Items Excluding Goodwill
-41,000
-41,000
-2,000
-1,000
8,000
Total Unusual Items
-41,000
-41,000
-2,000
-1,000
8,000
Normalized EBITDA
10,585,000
10,585,000
12,133,000
12,283,000
8,833,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-5,781
-5,781
-330
-139
800